1. 543. An Integrated Safety Analysis Comparing Once-Daily Doravirine (DOR) to Darunavir+Ritonavir (DRV+r) and Efavirenz (EFV) in HIV-1-Infected, Antiretroviral Therapy (ART)-Naïve Adults. (26th November 2018) Authors: Thompson, Melanie; Orkin, Chloe; Molina, Jean-Michel; Gatell, Jose; Sax, Paul; Cahn, Pedro; Squires, Kathleen; Zhou, Yan; Xu, Xia; Rodgers, Anthony; Kumar, Sushma; Teppler, Hedy; Martin, Elizabeth; Hanna, George; Hwang, Carey Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 626. The Efficacy and Safety of Maintenance with Doravirine Plus Two NRTIs after Initial Suppression in Adults with HIV-1 in the DRIVE-FORWARD Clinical Trial: Results from the Study Extension through 192 Weeks. (4th December 2021) Authors: Cahn, Pedro; Molina, Jean-michel; Lombaard, Johan; Squires, Kathleen; Kumar, Sushma; Wan, Hong; Teal, Valerie; Asante-Appiah, Ernest; Sklar, Peter; Martin, Elizabeth A; Lahoulou, Rima Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial. Issue 6 (August 2019) Authors: Gatell, Jose M; Morales-Ramirez, Javier O; Hagins, Debbie P; Thompson, Melanie; Arastéh, Keikawus; Hoffmann, Christian; Raffi, François; Osiyemi, Olayemi; Dretler, Robin; Harvey, Charlotte; Xu, Xia; Plettenberg, Andreas; Smith, Don E; Portilla, Joaquín; Rugina, Sorin; Kumar, Sushma; Frobose, Coll... Journal: Antiviral therapy Issue: Volume 24:Issue 6(2019) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial. Issue 5 (May 2018) Authors: Molina, Jean-Michel; Squires, Kathleen; Sax, Paul E; Cahn, Pedro; Lombaard, Johan; DeJesus, Edwin; Lai, Ming-Tain; Xu, Xia; Rodgers, Anthony; Lupinacci, Lisa; Kumar, Sushma; Sklar, Peter; Nguyen, Bach-Yen; Hanna, George J; Hwang, Carey Journal: Lancet Issue: Volume 5:Issue 5(2018) Page Start: e211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial. Issue 1 (January 2020) Authors: Molina, Jean-Michel; Squires, Kathleen; Sax, Paul E; Cahn, Pedro; Lombaard, Johan; DeJesus, Edwin; Lai, Ming-Tain; Rodgers, Anthony; Lupinacci, Lisa; Kumar, Sushma; Sklar, Peter; Hanna, George J; Hwang, Carey; Martin, Elizabeth Anne Journal: Lancet Issue: Volume 7:Issue 1(2020) Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial. (18th December 2020) Authors: Orkin, Chloe; Squires, Kathleen E; Molina, Jean-Michel; Sax, Paul E; Sussmann, Otto; Lin, Gina; Kumar, Sushma; Hanna, George J; Hwang, Carey; Martin, Elizabeth; Teppler, Hedy Journal: Clinical infectious diseases Issue: Volume 73:Number 1(2021) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial. (31st August 2018) Authors: Orkin, Chloe; Squires, Kathleen E; Molina, Jean-Michel; Sax, Paul E; Wong, Wing-Wai; Sussmann, Otto; Kaplan, Richard; Lupinacci, Lisa; Rodgers, Anthony; Xu, Xia; Lin, Gina; Kumar, Sushma; Sklar, Peter; Nguyen, Bach-Yen; Hanna, George J; Hwang, Carey; Martin, Elizabeth A Journal: Clinical infectious diseases Issue: Volume 68:Number 4(2019) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine. (1st April 2021) Authors: Nelson, Mark; Winston, Alan; Hill, Andrew; Mngqibisa, Rosie; Bassa, Ayesha; Orkin, Chloe; Rassool, Mohammed; Rodgers, Anthony; Teal, Valerie; Kumar, Sushma; Teppler, Hedy Journal: AIDS Issue: Volume 35:Number 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be NonInferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-Naïve Adults With HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial. (26th November 2018) Authors: Orkin, Chloe; Squires, Kathleen; Molina, Jean-Michel; Sax, Paul; Wong, Wingwai; Sussmann, Otto; Lin, Gina; Kumar, Sushma; Hanna, George; Hwang, Carey; Martin, Elizabeth; Teppler, Hedy Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LB2. Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial. (26th November 2018) Authors: Kumar, Princy; Johnson, Margaret; Molina, Jean-Michel; Rizzardini, Giuliano; Cahn, Pedro; Bickel, Markus; Mallolas, Josep; Zhou, Yan; Morais, Cristiana; Kumar, Sushma; Sklar, Peter; Hanna, George J; Hwang, Carey; Greaves, Wayne Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗